Cardiac Transitional Care Effectiveness: Does Overall Comorbidity Burden Matter?


Journal

The American journal of medicine
ISSN: 1555-7162
Titre abrégé: Am J Med
Pays: United States
ID NLM: 0267200

Informations de publication

Date de publication:
12 2021
Historique:
received: 29 05 2021
revised: 09 06 2021
accepted: 09 06 2021
pubmed: 18 7 2021
medline: 29 1 2022
entrez: 17 7 2021
Statut: ppublish

Résumé

Cardiovascular disease is the most common cause of mortality and hospitalization in the United States. Transitional care initiatives can improve outcomes for cardiac patients, but it is unclear whether patients with different baseline comorbidity burden benefit equally. We evaluated the effectiveness of the Bridging the Discharge Gap Effectively (BRIDGE) program, a nurse-practitioner-led transitional care clinic, in mitigating adverse clinical outcomes in cardiac patients with varying Charlson comorbidity index (CCI). We studied patients referred to BRIDGE between 2008 and 2017 postdischarge for a cardiac condition. Using proportional hazards regression models, we evaluated associations between attendance at BRIDGE and hospital readmission, emergency department (ED) visit, and a composite outcome consisting of readmission, ED visit, or mortality, and assessed interaction between BRIDGE attendance and CCI. Of 4559 patients, 3256 (71.4%) attended BRIDGE. In patients with low CCI, attendance at BRIDGE was inversely associated with hospital readmission (adjusted hazard ratio = 0.82, 95% confidence interval [CI]: 0.69, 0.97, P = .02) and the composite endpoint (adjusted hazard ratio = 0.84, 95% CI: 0.72, 0.98, P = .02). Associations of BRIDGE attendance with both readmission and ED visit were significantly weaker in patients with high CCI (adjusted P, interaction = .007 and .03, respectively). Overall, BRIDGE attendance was associated with an 11% lower hazard of developing the composite endpoint (95% CI: 2%, 19%, P = .01). Attendance at a transitional care clinic is inversely associated with risk of readmission and a composite endpoint in cardiac patients with low CCI. Future research should investigate modified transitional care programs in patients with varying comorbidity burden.

Sections du résumé

BACKGROUND
Cardiovascular disease is the most common cause of mortality and hospitalization in the United States. Transitional care initiatives can improve outcomes for cardiac patients, but it is unclear whether patients with different baseline comorbidity burden benefit equally. We evaluated the effectiveness of the Bridging the Discharge Gap Effectively (BRIDGE) program, a nurse-practitioner-led transitional care clinic, in mitigating adverse clinical outcomes in cardiac patients with varying Charlson comorbidity index (CCI).
METHODS
We studied patients referred to BRIDGE between 2008 and 2017 postdischarge for a cardiac condition. Using proportional hazards regression models, we evaluated associations between attendance at BRIDGE and hospital readmission, emergency department (ED) visit, and a composite outcome consisting of readmission, ED visit, or mortality, and assessed interaction between BRIDGE attendance and CCI.
RESULTS
Of 4559 patients, 3256 (71.4%) attended BRIDGE. In patients with low CCI, attendance at BRIDGE was inversely associated with hospital readmission (adjusted hazard ratio = 0.82, 95% confidence interval [CI]: 0.69, 0.97, P = .02) and the composite endpoint (adjusted hazard ratio = 0.84, 95% CI: 0.72, 0.98, P = .02). Associations of BRIDGE attendance with both readmission and ED visit were significantly weaker in patients with high CCI (adjusted P, interaction = .007 and .03, respectively). Overall, BRIDGE attendance was associated with an 11% lower hazard of developing the composite endpoint (95% CI: 2%, 19%, P = .01).
CONCLUSIONS
Attendance at a transitional care clinic is inversely associated with risk of readmission and a composite endpoint in cardiac patients with low CCI. Future research should investigate modified transitional care programs in patients with varying comorbidity burden.

Identifiants

pubmed: 34273282
pii: S0002-9343(21)00424-1
doi: 10.1016/j.amjmed.2021.06.018
pmc: PMC8688268
mid: NIHMS1734758
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1506-1513

Subventions

Organisme : NCATS NIH HHS
ID : TL1 TR002242
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Références

PLoS One. 2016 Oct 7;11(10):e0160492
pubmed: 27716841
J Am Geriatr Soc. 2017 Jul;65(7):1597-1608
pubmed: 28403508
BMC Health Serv Res. 2018 Aug 30;18(1):672
pubmed: 30165843
N Engl J Med. 2013 Jan 10;368(2):100-2
pubmed: 23301730
JAMA. 2019 Feb 26;321(8):753-761
pubmed: 30806695
JAMA Netw Open. 2020 Dec 1;3(12):e2027410
pubmed: 33270125
Online J Issues Nurs. 2015 Sep 30;20(3):1
pubmed: 26882510
JAMA Intern Med. 2016 Apr;176(4):484-93
pubmed: 26954564
J Gen Intern Med. 2019 Sep;34(9):1758-1765
pubmed: 31144279
J Am Geriatr Soc. 2003 Apr;51(4):549-55
pubmed: 12657078
J Am Heart Assoc. 2015 Dec 23;4(12):
pubmed: 26702083
JAMA. 2010 May 5;303(17):1716-22
pubmed: 20442387
N Engl J Med. 2009 Apr 2;360(14):1418-28
pubmed: 19339721
J Clin Epidemiol. 1994 Nov;47(11):1245-51
pubmed: 7722560
JAMA Intern Med. 2017 Feb 1;177(2):166-175
pubmed: 28027338
J Am Geriatr Soc. 2017 Jun;65(6):1119-1125
pubmed: 28369722
Prof Case Manag. 2009 May-Jun;14(3):135-40; quiz 141-2
pubmed: 19474639
J Am Geriatr Soc. 2015 Aug;63(8):1583-93
pubmed: 26289684
Ann Intern Med. 2014 Jun 3;160(11):774-84
pubmed: 24862840
Circulation. 2012 Jul 24;126(4):501-6
pubmed: 22825412
Eur Heart J. 1998 Aug;19(8):1254-60
pubmed: 9740348
Circulation. 2018 Mar 20;137(12):e67-e492
pubmed: 29386200
Eur Heart J. 2003 Jun;24(11):1014-23
pubmed: 12788301

Auteurs

Joshua Garfein (J)

Michigan Medicine, Ann Arbor.

George Cholack (G)

Michigan Medicine, Ann Arbor; Oakland University William Beaumont School of Medicine, Rochester, Mich.

Rachel Krallman (R)

Michigan Medicine, Ann Arbor.

Delaney Feldeisen (D)

Michigan Medicine, Ann Arbor.

Daniel Montgomery (D)

Michigan Medicine, Ann Arbor.

Eva Kline-Rogers (E)

Michigan Medicine, Ann Arbor.

Kim Eagle (K)

Michigan Medicine, Ann Arbor.

Melvyn Rubenfire (M)

Michigan Medicine, Ann Arbor.

Sherry Bumpus (S)

Michigan Medicine, Ann Arbor; Eastern Michigan University, School of Nursing, Ypsilanti. Electronic address: sbumpus2@emich.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH